Purpose of the development: Diagnostics. To determine the malignant renal tumors and colon cancer, as well as the establishment of protocols for their use in clinical laboratories.

Recommended application field: Molecular genetic diagnostic laboratories hospitals, cancer hospitals and branches of institutions of Ministry of Health of Ukraine.

Advantages over analogues: The high sensitivity of established test systems allow them to be used for early diagnosis of human cancer, outcries of the population at risk. Domestic analogues of this development does not exist. Development became the winner of the Forum "Science Business Innovation - 2015", which was highly appreciated among NDI Foundation business analysts and recognized as promising for implementation in production.

The development stage readiness: Introduced in production

Description of the development:
()
The diagnostic kit developed molecular genetic prognostic markers for determining malignancy of renal tumors and colon cancer, as well as the establishment of protocols for their use in clinical laboratories.

corresponds technical description
Guarantees stable results getting

Possibility of transfer abroad:
Combinated reduction to industrial level
Realization of finished commodity
Joint production, sale, exploitation

Photo

Country Ukraine

For additional information turn to:
E-mail: gal@uintei.kiev.ua